Clinical Trial Update: Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treatment for secondary hyperparathyroidism in end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Snippet

Sponsor: Amgen | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED